Whole genome sequencing to help you improve your health and longevity. $999. U.S. price.
A simple screening test to help you understand your risk for hereditary breast and ovarian cancer.
Screening test of 26 genes, including BRCA1 and BRCA2, for increased risk of developing breast, ovarian, and other inherited cancers.
Maternal blood-based non-invasive screening that predicts the presence of Down Syndrome (T21), Edwards Syndrome (T18), and Patau Syndrome (T13).
Saliva-based screening of prospective or currently pregnant parents to see if they carry inherited and rare conditions such as cystic fibrosis.
Comprehensive genetic screening of newborns for early childhood diseases.
Industry-leading genetic tests, whole genome sequencing, and interpretation for your patients.
Customized, fully integrated, research-only whole genome sequencing services.
Industry-leading genetic tests and genome sequencing solutions.
We are a passionate and dynamic group of scientists, engineers, genetic counselors, business folk, and designers. Our goal: empower people to live healthier, longer.
But, our story began in the 1970s with a young student passionate about one thing, DNA. George Church's work set in motion countless genetic discoveries, including the Human Genome Project, the first initiative to map all genes in the human genome.
George, along with a group of visionaries and scientists, including leaders from Harvard Medical School's Personal Genome Project, co-founded Veritas.
Founder and Chief Executive Officer
Life sciences entrepreneur. Formerly CEO AbVitro, Head of Corp. Dev. FORMA Therapeutics.
Founder and Chief Scientific Officer
Harvard Medical School, Church Lab PhD Director of Gerontology - Personal Genome Project - Harvard Medical School.
Founder and Managing Director, Asia
International Business leader formerly responsible for Asia strategy and new products at Amgen and Pfizer. MBA from MIT Sloan and PhD in Chemistry.
Chief Commercial Officer and General Counsel
Former VP, Corporate Development and General Counsel at LoJack Corporation. JD from Boston University Law School.
Chief Operating Officer
Former VP at Cimpress and Medullan. Former COO of True Office. BS from Cornell University. MBA from the University of Rochester.
Chief Marketing and Design Officer
Former Life Sciences Chief Strategist at IDEO. Former Principal at Boston Consulting Group. Co-founded Harvard Business School’s Life Sciences Project.
Doctor of Medicine, University of Miami School of Medicine. Former Assistant Professor, Brown University School of Medicine, and former Teaching Fellow, Boston University School of Medicine.
VP Product Development
Formerly senior roles with Roche Diagnostics (454 Life Sciences). PhD from University of Chicago and post-doctorate from Yale University.
Head of Bioinformatics
Former Senior Analyst at Joint Genome Institute. Human Genome Project. Postdoctoral Fellow, Broad Institute of MIT and Harvard.
Director of Clinical Services, US
ABGC board-certified genetic counselor licensed in 16 states and has over 17 years of counseling experience spanning several clinical areas.
VP of Clinical Affairs
A board-certified clinical molecular geneticist, and also an Associate Professor of Pathology at Harvard Medical School.
Professor of Genetics at Harvard Medical School and MIT. Founding core member of Wyss Institute for Biologically Inspired Engineering at Harvard.
Scientific leader in personalized oncology, targeted oncology therapeutics, and biomarker research. Currently CSO Xtuit. Former executive with Metamark Genetics, Daiichi Sankyo, Merck and Serono.
Former EVP and CSO at Wyeth, Faculty at Harvard Medical School and Dana Farber. Currently Adjunct Professor of Medicine at Johns Hopkins Medical School.
Previously Amgen Executive Director, Medical Sciences, and VP, Proteomics, at Celera Genomics. Currently VP, Biomarker Sciences, at Gilead Sciences, Inc.
Former NASA Astronaut and physiologist with expertise in human adaptation to extreme environments. Professor of Practice, Arizona State University. Product developer. Stanford MD.
Professor, Biomedical Informatics and Medicine, Harvard Medical School. Chair in Computational Genomics. Research Geneticist, Brigham and Women’s. Associate Member of Broad Institute.
Director emeritus at Max Planck Institut of Molecular Genetics, CEO/CSO Dahlem Centre for Genome Research & Medical System Biology, and Founder of Alacris Theranostics Gmbh.
Medical Geneticist and Physician Scientist. Associate Physician, Brigham and Women’s Hospital. Assistant Professor of Medicine, Harvard Medical School. Director, VA Boston Genetic Service. Associate Member, Broad Institute.
Medical Geneticist and Physician Scientist. Professor of Medicine, Division of Genetics at Brigham & Women’s Hospital and Harvard Medical School. Director of the Genomes2People Research Program. Associate Member, Broad Institute.
Former President Genzyme Genetics, President Genzyme BioSurgery. Dartmouth MBA.
Founder, Director of LabCentral and Chairman of Boston Heart Diagnostics. 25+ years life sciences venture capital.
Partner with Lilly Asia Ventures. Formerly McKinsey’s healthcare practice. MBA Harvard Business School. BA Neurobiology from Harvard.
99 Conifer Hill Drive
Danvers, MA 01923, USA
11th Floor, LEO Building, No.2 Science & Technology Park,
Hangzhou Eco-Tech Development Area,
Hangzhou, China 310018
Room 805, Platinum Tower, 233 Taicang Road
Huangpu District, Shanghai, China 200020
We are always looking for talented individuals who might be interested in joining our passionate, energized and dedicated team of professionals. To apply for any of our current openings below, please send your resume along with a cover letter to email@example.com. We do not accept third party solicitation for employment.